Table.
Interventions aimed at reducing readmissions and/or evaluating associated costs
Authors | Title | Population | Study design | Intervention | Outcomes-utilization | Outcomes-costs | Outcomes-other |
---|---|---|---|---|---|---|---|
Not bundled | |||||||
**Coughlin, et al40 | Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD | Patients with severe COPD in the US | Economic model | Home NIV | N/A | Cost savings at 30 and 90 days | N/A |
**Silver PC, et al. A52 | Respiratory Therapist Disease Management Program for Subjects Hospitalized With COPD | Patients with spirometry confirmed COPD >18 to <65 years at high risk for readmission N=478 |
RCT | Respiratory Therapists | 6 month ED visits/Rehospitalizations combined and separate: No difference for combined ED and hospitalization (p=0.8); no difference for COPD-related or all-cause ED visit (NS); mult non-hosp ED visits fewer in intervention group (p=0.001); at least one COPD admission (p=0.04) and multiple readmission (p=0.02) | N/A | N/A |
**Agarwal A, et al.49 | Process and Outcome Measures among COPD Patients with a Hospitalization Cared for by an Advance Practice Provider or Primary Care Physician | Medicare patients with at least one hospitalization in 2010 n=7257 |
Cross sectional retrospective cohort study | Provider type (primary care/APP) | Admissions (NS); 30 day readmissions (NS); AAP patients lower rates of ED visits | N/A | Process measures: APP patients more likely to prescribe short acting bronchodilators, oxygen therapy, and consult pulmonology; higher rates of follow-up with pulmonary specialty within 30 days |
**Rinne ST, et al.51 | Impact of Multisystem Health Care on Readmission and Follow-up Among Veterans Hospitalized for Chronic Obstructive Pulmonary Disease | VA patients Medicare-eligible veterans n=4129 |
Retrospective cohort study | Use of no-VA outpatient care | 30 day readmission: no association between non-VA care and any-cause readmission; increased COD-specific readmission risk with dual0-care and Medicare only. | N/A | 30 day follow up: Medicare only outpatient care associated with lower rates of follow up |
**Abusaada K, al.50 | Comparison of hospital outcomes and resource use in acute COPD exacerbation patients managed by teaching versus nonteaching services in a community hospital | n=1419 | Retrospective cohort study | Teaching vs. non-teaching services | 30 day readmissions (NS) | Risk-adjusted cost (observed/expected) was lower in teaching vs. nonteaching group (0.66 vs. 1.06; p<0.001) | LOS lower in teaching group (p<0.001), mortality (NS); use of consults was lower in teaching group |
**Agee J, et al..53 | Reducing Chronic Obstructive Pulmonary Disease 30-Day Readmissions: A Nurse-Led Evidence-Based Quality Improvement Project | Adults, 18 years and older with a diagnosis of COPD at discharge | QI | Multidisciplinary team led by a chief nursing officer using the chronic care model with three teams: education, standardized pathway, and community teams | Goal of 10% reduction in COPD readmissions within 30 days of discharge from ED or hospitalizations; Results: 7.6% reduction in overall COPD admissions; 46% in COPD readmissions | N/A | Quality of life: St. George Respiratory Questionnaire: improved from 50.99 to 42.51 (delta of 8.48; delta of 8 units corresponds to ‘moderately efficacious”) |
Bundled | |||||||
**Parikh R, et al.54 | COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates. | Patients admitted with AECOPD n=44 |
Prospective, observational | COPD exacerbation bundle driven by guideline recommendations for AECOPD with multidisciplinary team: standard nursing protocols, patient education for inhaler technique, mediation options, order set, incorporated into their EHR. | 30-day readmission rates (9.1% vs 54.4% in controls; P -value = 0.001), and 60-day readmission rates (22.7% vs 77% in controls; P-value = 0.0003) decreased in the care bundle group. | Ninety-day hospital costs had a significant difference in the care bundle group (US$7,652 vs US$19,954 in controls; P-value = 0.044). | LOS: 51.2 vs. 101.1 hours (p=0.001); 100% vs. 27.3% inhaler teaching (p<0.001), 59.1% vs. 18.2% pulmonologist follow-up post discharge (p=0.005), mean reduction in time to steroid administration (p=0.015) |
**Zafar MA, et al.55 | Reliable adherence to a COPD care bundle mitigates system-level failures and reduces COPD readmissions: a system redesign using improvement science. | Patients admitted with COPD | QI | Multidisciplinary team: COPD care bundle of five components-appropriate inhaler regimen; 30-day inhaler supply; personalized inhaler education; standardized discharge instructions/education; follow up within 15 days | Any unplanned readmission within 30 days of discharge after AECOPD admission based on number of bundle components received: overall declined from 22.7% to 14.7%; those with 4 or 5 bundle components were 12.5% and 10.9%; while those with two or more missed was 26.5% (p<0.05). | n/a | Process measures: adherence to COPD care bundle components and to each individual component(Goal 90%)-increased from 50% to 89% |
**Bhatt SP, et al.56 | Results of a Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions | Medicare-only patients with AECOPD n=78 |
Pre/post | BPCI program: comprehensive COPD multi-disciplinary intervention focusing on inpatient, transitional, and outpatient care | All cause 30-day readmissions compared to historical controls: No differences (p=0.7); 90-day readmissions (p=0.2). | Costs after index hospitalization compared with BPCI target prices: No differences for hospital costs/savings; no difference in per-patient costs for index PBCI admission vs 2012 control subject admissions | BPCI patients were more like to receive vaccines (influenza and pneumococcal), be referred to pulmonary rehabilitation, have scheduled and attend follow-up appointments, and for active smokers to receive counselling (p<0.05) |